-
Summer 2018 | Live Blog | Comorbidities in Rosacea and Acne: Fact or Fiction?
Gina Fragione, MPAS, PA-C presented a lecture on Comorbidities in Rosacea and Acne: Fact or Fiction at the SDPA Annual Summer Conference. She began by discussing the pathophysiology of rosacea as primarily an inflammatory disorder consisting of a dysregulation of innate an adaptive immune system, and that it shares a […]
June 28, 2018
-
Summer 2018 | Live Blog | Comorbidities in Psoriasis: Fact or Fiction?
Did you know that over 20 comorbidities have been linked to Atopic Dermatitis in 2018? Dr. Robert Sidbury from Seattle Children’s Hospital helped attendees of the SDPA Summer Conference sift through the published data related to atopic comorbidities. Dr. Sidbury relayed that it is an “incredibly dynamic” time in the […]
June 28, 2018
-
Summer 2018 | Live Blog | Product Theater | Tremfya: A Selective IL-23 Inhibitor with Pivotal Studies vs. Adalimunab
For the first product theater of the SDPA Annual Summer Conference, Cynthia Trickett, PA-C, reviewed Tremfya. Ms. Trickett specializes in the treatment of patients with psoriatic disease and discussed Tremfya as a first line therapy medication for patients 18 years or older with moderate to severe plaque psoriasis. As Ms. […]
June 28, 2018
-
Summer 2018 | Live Blog | Lessons From Literature 2018
Dr. Rosen began Day 1 of the SDPA Annual Summer Conference this morning with a complementary message thanking PAs for being “the most open to adopting new technology and new drugs and pushing your doctors into the 21st century”. Dr. Rosen also vocalized his continued support of PAs! He started […]
June 28, 2018
-
Summer 2018 | Live Blog | An In-Depth Look at Dermoscopy
The SDPA Annual Summer Conference kicked off the morning pre-conference track with in an-depth look at dermoscopy. Dr. Jennie Clarke provided a quick overview of the history of dermoscopy while emphasizing that dermoscopy is not used for diagnosis but for guidance to determine the need to biopsy suspicious lesions. She […]
June 27, 2018
-
Is There a Link Between Severe Atopic Eczema and Cardiovascular Disease?
Atopic eczema is a common relapsing condition the affects up to 10% of adults. Because of its systemic inflammatory component, it is thought that atopic eczema may contribute to cardiovascular outcomes, but it is not known whether the cardiovascular risks may correlate with the severity of disease. A recent study […]
June 25, 2018
